Breast MR builds its role among high-risk patients

Article

New data reported at the RSNA meeting are refueling the drive for further utilization of MR imaging in the triage and characterization of breast cancer in women at high risk for disease.

New data reported at the RSNA meeting are refueling the drive for further utilization of MR imaging in the triage and characterization of breast cancer in women at high risk for disease.

The International Breast MRI Consortium (IBMC) trial, which compared MR and screening mammography in women at genetically high risk for breast cancer, found that MR screening can detect breast cancers missed by clinical examination and x-ray mammography, according to Dr. Constance D. Lehman and colleagues at the University of Washington, Seattle.

Also participating in the IBMC trial, Dr. Mitchell D. Schnall and colleagues at the University of Pennsylvania found an unusually low sensitivity for MR (88.1%) but a relatively high specificity (67.4%). MR could predict diagnosis in patients with suspicious lesions identified before biopsy.

Dr. Sina Meisamy and colleagues at the University of Minnesota found that adding quantitative hydrogen-1 MR spectroscopy to assess choline-containing compounds bolstered four independent radiologists' ability to characterize tumors. All four readers improved their sensitivity, specificity, and accuracy.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.